Condizione: New.
Lingua: Inglese
Editore: H N H International Limited, 2024
ISBN 10: 1032601221 ISBN 13: 9781032601229
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 212 1st edition NO-PA16APR2015-KAP.
Lingua: Inglese
Editore: H N H International Limited, 2024
ISBN 10: 1032601221 ISBN 13: 9781032601229
Da: Majestic Books, Hounslow, Regno Unito
EUR 39,03
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. 212.
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Condizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: H N H International Limited, 2024
ISBN 10: 1032601221 ISBN 13: 9781032601229
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 38,60
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. 212.
Condizione: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
EUR 46,96
Quantità: 4 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Condizione: NEW.
Lingua: Inglese
Editore: Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032601221 ISBN 13: 9781032601229
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 53,87
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: New. Today, scientists are expected to be more accountable and transparent than at any other time in history. Globally, the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefits from the innovative contributions made by researchers. It is, therefore, more important than ever that ethics, transparency, and professionalism explicitly guide research integrity.Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at the undergraduate nor at the postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness, and trustworthiness of clinical trials and filling a current void in the market.Key Features: The first book on clinical trial integrity Provides clear guidance on how to ensure probity in peer review, appraisal of trials, and investigation of complaints concerning misconduct in clinical trials Trains and supports researchers globally on how to undertake trials with integrity Ensures that the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be metThis book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology, and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, and funders and regulators of clinical trials.
Lingua: Inglese
Editore: Taylor & Francis Ltd, London, 2024
ISBN 10: 1032601221 ISBN 13: 9781032601229
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Paperback. Condizione: new. Paperback. Today, scientists are expected to be more accountable and transparent than at any other time in history. Globally, the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefits from the innovative contributions made by researchers. It is, therefore, more important than ever that ethics, transparency, and professionalism explicitly guide research integrity.Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at the undergraduate nor at the postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness, and trustworthiness of clinical trials and filling a current void in the market.Key Features: The first book on clinical trial integrity Provides clear guidance on how to ensure probity in peer review, appraisal of trials, and investigation of complaints concerning misconduct in clinical trials Trains and supports researchers globally on how to undertake trials with integrity Ensures that the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be metThis book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology, and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, and funders and regulators of clinical trials. Today scientists are expected to be more accountable and transparent than at any time in history. Globally the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefit from the innovative contributions made by researchers. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Lingua: Inglese
Editore: Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032601221 ISBN 13: 9781032601229
Da: Rarewaves USA, OSWEGO, IL, U.S.A.
Paperback. Condizione: New. Today, scientists are expected to be more accountable and transparent than at any other time in history. Globally, the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefits from the innovative contributions made by researchers. It is, therefore, more important than ever that ethics, transparency, and professionalism explicitly guide research integrity.Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at the undergraduate nor at the postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness, and trustworthiness of clinical trials and filling a current void in the market.Key Features: The first book on clinical trial integrity Provides clear guidance on how to ensure probity in peer review, appraisal of trials, and investigation of complaints concerning misconduct in clinical trials Trains and supports researchers globally on how to undertake trials with integrity Ensures that the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be metThis book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology, and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, and funders and regulators of clinical trials.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 42,09
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New.
Da: Chiron Media, Wallingford, Regno Unito
EUR 45,54
Quantità: 4 disponibili
Aggiungi al carrellopaperback. Condizione: New.
EUR 50,80
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 49,21
Quantità: 1 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 49,04
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 55,22
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New.
Da: Revaluation Books, Exeter, Regno Unito
EUR 69,22
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 216 pages. 9.18x6.12x9.21 inches. In Stock.
EUR 42,10
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: NEW.
Lingua: Inglese
Editore: TAYLOR & FRANCIS NP EXCLUSIVE(CBS), 2025
ISBN 10: 1032601221 ISBN 13: 9781032601229
Da: UK BOOKS STORE, London, LONDO, Regno Unito
EUR 88,42
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Lingua: Inglese
Editore: Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032601221 ISBN 13: 9781032601229
Da: Rarewaves USA United, OSWEGO, IL, U.S.A.
Paperback. Condizione: New. Today, scientists are expected to be more accountable and transparent than at any other time in history. Globally, the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefits from the innovative contributions made by researchers. It is, therefore, more important than ever that ethics, transparency, and professionalism explicitly guide research integrity.Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at the undergraduate nor at the postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness, and trustworthiness of clinical trials and filling a current void in the market.Key Features: The first book on clinical trial integrity Provides clear guidance on how to ensure probity in peer review, appraisal of trials, and investigation of complaints concerning misconduct in clinical trials Trains and supports researchers globally on how to undertake trials with integrity Ensures that the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be metThis book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology, and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, and funders and regulators of clinical trials.
EUR 53,42
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Khalid S. Khan is Beatriz Galindo Distinguished Investigator at the University of Granada, Spain, and has been Sims Black Fellow of the UK Royal College of Obstetricians and Gynaecologists, Spinoza Professor at the University of Amsterda.
Da: preigu, Osnabrück, Germania
EUR 43,80
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Integrity of Randomized Clinical Trials | How to prevent research misconduct and ensure transparency | Khalid S. Khan | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2024 | CRC Press | EAN 9781032601229 | Verantwortliche Person für die EU: Taylor & Francis Verlag GmbH, Kaufingerstr. 24, 80331 München, gpsr[at]taylorandfrancis[dot]com | Anbieter: preigu.
Lingua: Inglese
Editore: Taylor & Francis Ltd, London, 2024
ISBN 10: 1032601221 ISBN 13: 9781032601229
Da: AussieBookSeller, Truganina, VIC, Australia
EUR 86,42
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: new. Paperback. Today, scientists are expected to be more accountable and transparent than at any other time in history. Globally, the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefits from the innovative contributions made by researchers. It is, therefore, more important than ever that ethics, transparency, and professionalism explicitly guide research integrity.Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at the undergraduate nor at the postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness, and trustworthiness of clinical trials and filling a current void in the market.Key Features: The first book on clinical trial integrity Provides clear guidance on how to ensure probity in peer review, appraisal of trials, and investigation of complaints concerning misconduct in clinical trials Trains and supports researchers globally on how to undertake trials with integrity Ensures that the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be metThis book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology, and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, and funders and regulators of clinical trials. Today scientists are expected to be more accountable and transparent than at any time in history. Globally the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefit from the innovative contributions made by researchers. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Lingua: Inglese
Editore: Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032601221 ISBN 13: 9781032601229
Da: Rarewaves.com UK, London, Regno Unito
EUR 49,95
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: New. Today, scientists are expected to be more accountable and transparent than at any other time in history. Globally, the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefits from the innovative contributions made by researchers. It is, therefore, more important than ever that ethics, transparency, and professionalism explicitly guide research integrity.Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at the undergraduate nor at the postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness, and trustworthiness of clinical trials and filling a current void in the market.Key Features: The first book on clinical trial integrity Provides clear guidance on how to ensure probity in peer review, appraisal of trials, and investigation of complaints concerning misconduct in clinical trials Trains and supports researchers globally on how to undertake trials with integrity Ensures that the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be metThis book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology, and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, and funders and regulators of clinical trials.
Da: Revaluation Books, Exeter, Regno Unito
EUR 55,58
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 216 pages. 9.18x6.12x9.21 inches. In Stock. This item is printed on demand.